Healthcare provider profile · identity verified

Steven C Bade, MD

Family Practice · LITITZ, PA · NPI 1811933534

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	205	47
Atorvastatin Calcium	Atorvastatin Calcium	192	45
Simvastatin	Simvastatin	182	44
Omeprazole	Omeprazole	142	29
Metoprolol Succinate	Metoprolol Succinate	140	34
Levothyroxine Sodium	Levothyroxine Sodium	131	28
Lisinopril	Lisinopril	125	29
Gabapentin	Gabapentin	117	23
Tramadol Hcl	Tramadol Hcl	110	15
Duloxetine Hcl	Duloxetine Hcl	99	12
Pioglitazone Hcl	Pioglitazone Hcl	98	21
Lorazepam	Lorazepam	92	15
Rosuvastatin Calcium	Rosuvastatin Calcium	89	22
Metformin Hcl	Metformin Hcl	85	24
Losartan Potassium	Losartan Potassium	84	20
Metformin Hcl Er	Metformin Hcl	82	23
Celecoxib	Celecoxib	80	14
Sertraline Hcl	Sertraline Hcl	78	18
Oxycodone Hcl	Oxycodone Hcl	77	12
Telmisartan	Telmisartan	74	18
Famotidine	Famotidine	71	20
Pantoprazole Sodium	Pantoprazole Sodium	71	21
Bupropion Xl	Bupropion Hcl	65	suppressed
Glipizide Er	Glipizide	62	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	60	24
Metoprolol Tartrate	Metoprolol Tartrate	60	16
Donepezil Hcl	Donepezil Hcl	58	15
Trazodone Hcl	Trazodone Hcl	55	13
Diazepam	Diazepam	48	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	48	11
Montelukast Sodium	Montelukast Sodium	46	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	45	13
Fluticasone Propionate	Fluticasone Propionate	43	15
Pregabalin	Pregabalin	43	suppressed
Alendronate Sodium	Alendronate Sodium	42	suppressed
Furosemide	Furosemide	42	15
Atenolol	Atenolol	41	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	41	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	40	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	38	11
Allopurinol	Allopurinol	37	13
Enalapril Maleate	Enalapril Maleate	36	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	35	suppressed
Ramipril	Ramipril	35	suppressed
Buspirone Hcl	Buspirone Hcl	34	suppressed
Januvia	Sitagliptin Phosphate	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	suppressed
Olanzapine	Olanzapine	32	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Baclofen	Baclofen	30	16
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Glimepiride	Glimepiride	30	suppressed
Jardiance	Empagliflozin	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Xarelto	Rivaroxaban	29	suppressed
Benazepril Hcl	Benazepril Hcl	27	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	27	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Potassium Chloride	Potassium Chloride	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Prednisone	Prednisone	23	17
Warfarin Sodium	Warfarin Sodium	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	suppressed
Amoxicillin	Amoxicillin	20	14
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Eliquis	Apixaban	20	suppressed
Cilostazol	Cilostazol	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	11
Terazosin Hcl	Terazosin Hcl	18	suppressed
Carvedilol	Carvedilol	17	suppressed
Mometasone Furoate	Mometasone Furoate	17	suppressed
Morphine Sulfate Er	Morphine Sulfate	17	suppressed
Ozempic	Semaglutide	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Valsartan	Valsartan	17	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Naproxen	Naproxen	16	suppressed
Oxycontin	Oxycodone Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Estradiol	Estradiol	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Azithromycin	Azithromycin	14	14
Finasteride	Finasteride	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Meloxicam	Meloxicam	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Cefuroxime	Cefuroxime Axetil	12	11
Chlorthalidone	Chlorthalidone	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Glipizide	Glipizide	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Methylphenidate Hcl Er (Cd)	Methylphenidate Hcl	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Irbesartan	Irbesartan	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error